Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 12.293% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cc1cn(C2OC[C@@H](O)[C@@H]2CO)c(=O)[nH]c1=O
b: CC(C)NC(=O)c1ccc2c(c1)N(CC(=O)Nc1ccccc1F)C(=O)C(C)(C)O2
c: O=S(=O)(c1ccc(Oc2ncnc3scc(-c4ccccc4)c23)cc1)N1CCOCC1
Answer: a. Cc1cn(C2OC[C@@H](O)[C@@H]2CO)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cn(C2OC[C@@H](O)[C@@H]2CO)c(=O)[nH]c1=O
Cc1cn(C2OC[C@@H](O)[C@@H]2CO)c(=O)[nH]c1=O
1-[(3S,4S)-4-hydroxy-3-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione